Professional Documents
Culture Documents
• Thyroid agents
• Antithyroid agents
• Radiation therapy for hyperthyroidism
• Glucocorticoids
Chapter 28
Drugs for Diabetes Mellitus
Diabetes Mellitus (DM)
• The pancreas is the main organ involved in diabetes
• Insulin is released when blood glucose increases
• Glucagon is released when blood glucose decreases
• Insulin assists in glucose transport
• Without insulin, glucose cannot get INTO the cell
• It is just like a “key” to a door into the cell
• REMEMBER other drugs and hormones can affect
blood glucose levels
47
Diabetes Mellitus (DM)
Type 1 DM Type 2 DM
• No insulin secretion
• ↓ Insulin secretion and/or
• Treatment: • ↓ sensitivity to insulin
• Lifestyle modifications • Treatment:
• Insulin • Lifestyle modifications
and possibly:
• Oral antihyperglycemic agents
• Insulin
Blood Glucose
• There are many target blood glucose levels,
see Table 40.1
• For testing purposes, we will use
4 - 6 mmol/L
• as the normal range of blood glucose
S & S of Blood Glucose Abnormalities
Hypoglycemia Hyperglycemia
Fig. 52-1. Normal endogenous insulin secretion. In the first hour or two after meals, insulin concentrations rise
rapidly in blood and peak at about 1 hour. After meals, insulin concentrations promptly decline toward
preprandial values as carbohydrate absorption from the gastrointestinal tract declines. After carbohydrate
absorption from the gastrointestinal tract is complete and during the night, insulin concentrations are low
and fairly constant, with a slight increase at dawn.
40-59
Sulfonylureas
• Stimulate release of insulin and increase sensitivity of
receptors
• Most common adverse effect is hypoglycemia
• Also include weight gain, GI distress, hepatotoxicity
• Do not take with alcohol- causes Antabuse-like reaction
• Prototype Drug: glyburide
Meglitinides
• Stimulate release of insulin
• Hypoglycemia is a common adverse
effect
• Work very similarly to sulfonylureas
Biguanides
• Decreases hepatic production of glucose
• Does not stimulate insulin release by pancreas
• Titrate slowly to avoid GI adverse effects
• Does not cause hypoglycemia or cause weight gain
• First-line therapy
• Prototype Drug: Metformin
Thiazolidediones
• Decrease insulin resistance/ inhibit gluconeogenesis
• May take 3-4 months for onset to occur
• Adverse effects of fluid retention, headache, weight gain
• Contraindicated in heart failure or pulmonary edema
Alpha-Glucosidase Inhibitors
• Act by delaying glucose digestion
• Some minor GI adverse effects
• Do not cause hypoglycemia when used alone
• Monitor for hypoglycemia when used with glyburide
or insulin
Oral Antihyperglycemics
Oral Antihyperglycemics (cont.)
Newer agents of
Oral Anti-hyperglycemics
• Incretins
• Incretins are hormones that signal insulin secretion to
increase and glucose production in the liver to stop
• Prototype Drug: saxagliptin (Onglyza)
• DPP4 inhibitors
• The DPP4 enzyme breaks down incretins, so inhibiting
their breakdown allows for improved insulin secretion
and reduces glucose production
• Prototype Drug: sitagliptin (Januvia)
Health teaching: Diabetes
Teach client to:
• Check blood glucose and eat simple sugar at first sign of
hypoglycemia; if symptoms do not improve call 911
• Exercise may increase insulin needs
• ALWAYS carry source of simple sugar in case of hypoglycemia
Health Teaching: Diabetes
• If blood glucose less than 4 mmol/L, take a fast-acting
carbohydrate; 15g of glucose tablets, 3 tsp sugar, ½ cup
orange juice
• Repeat blood sugar in 15 minutes if blood glucose still less
than 4 mmol/L and if there is more than one hour until the
next meal, eat a snack of a starch and protein (cheese and 6
crackers, or half a peanut butter sandwich)
Drug Classes to know for Testing
• Insulin:
• Rapid acting
• Regular/fast acting
• Intermediate acting
• Long-acting
• Extended long-acting
Drug Classes to know for Testing
• Oral Anti-hyperglycemics:
• Sulfonylureas
• Meglitinides
• Biguanides
• Thiazolidinediones
• Alpha-glucosidase inhibitors